Epinephrine (Epinephrine) Patent Expiration, LOE Window & CMS Spending

Epinephrine (Epinephrine) by Bpi Labs: FDA Orange Book LOE 2045-01-17, 1 AB generics, $382.0M 2024 CMS Part D & Medicaid spend, and 5 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorBpi Labs
FDA Application & PathwayN205029 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2045-01-17
Orange Book Patents (*PED Extensions)1 patents (0 *PED)
Active AB-Rated Generic Competitors1
2024 CMS Total Public Spend$382.0M
2024 Medicare Part D Spend$119.3M
2024 Medicaid Spend$262.7M
Reported Wholesale Price Change (CA SB 17)5 WAC filings (max 77.2% 2-yr change)